Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Novartis to buy radiology drug specialist Mariana for $1 billion

    www.aol.com/news/novartis-buy-radiology-drug...

    By Andrey Sychev and Ludwig Burger (Reuters) - Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer ...

  3. Vasant Narasimhan - Wikipedia

    en.wikipedia.org/wiki/Vasant_Narasimhan

    Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey before joining Novartis in 2005, where he has held a range of leadership roles, including Global Head of Development for Novartis Vaccines and Global Head of Drug Development & Chief Medical ...

  4. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...

  5. American Society of Clinical Oncology - Wikipedia

    en.wikipedia.org/wiki/American_Society_of...

    The American Society of Clinical Oncology ( ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, it has nearly 45,000 members worldwide.

  6. Novartis to acquire cancer-focused MorphoSys for $2.9 billion

    www.aol.com/news/novartis-acquire-cancer-drug...

    (Reuters) -Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros ($2.9 billion), adding a promising rare bone-marrow cancer treatment ...

  7. Novartis begins tender offer for cancer-focused MorphoSys - AOL

    www.aol.com/news/novartis-begins-tender-offer...

    BERLIN (Reuters) -Novartis said on Thursday it has launched a tender offer to acquire MorphoSys, a German developer of cancer treatments, for an aggregate 2.7 billion euros ($2.9 billion).

  8. Imatinib - Wikipedia

    en.wikipedia.org/wiki/Imatinib

    Imatinib is a 2- phenyl amino pyrimidine derivative that functions as a specific inhibitor of a number of tyrosine kinase enzymes. It occupies the TK active site, leading to a decrease in activity. There are a large number of TK enzymes in the body, including the insulin receptor.

  9. WHO issues warnings on fake copies of Novo Nordisk's ... - AOL

    www.aol.com/news/issues-warnings-fake-diabetes...

    June 20, 2024 at 1:25 PM. (Reuters) - The World Health Organization on Thursday issued warnings on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug ...